These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14996586)

  • 1. Use of glitazones in cardiac patients: a case for B-type natriuretic peptide monitoring?
    El-Muayed M; Lavis VR; Safi HJ; Fuentes F
    Am J Cardiol; 2004 Mar; 93(5):600-2. PubMed ID: 14996586
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain naturetic peptide (BNP) and diabetes mellitus.
    Ng LL
    Diabet Med; 2004 May; 21 Suppl 3():8-10. PubMed ID: 15089779
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diabetes, heart, and glitazones].
    Philippe J
    Rev Med Suisse Romande; 2004 Mar; 124(3):133-5. PubMed ID: 15095655
    [No Abstract]   [Full Text] [Related]  

  • 4. Approach to the management of diabetic patients with heart failure: role of thiazolidinediones.
    Fonarow GC
    Am Heart J; 2004 Oct; 148(4):551-8. PubMed ID: 15459582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protecting the heart while controlling blood sugar. New guidelines help define and refine the use of two diabetes drugs that could be a boon for people who also have heart disease.
    Harv Heart Lett; 2004 Mar; 14(7):1. PubMed ID: 15044139
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of glitazones on the progression of type 2 diabetes and on cardiovascular endpoints].
    Schatz H
    Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1825-30. PubMed ID: 16052448
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic significance of adipocytokines and extracellular matrix activity in heart failure patients with high B-type natriuretic peptide.
    Karadurmus N; Naharci MI
    Clin Biochem; 2010 Jun; 43(9):774; author reply 773. PubMed ID: 20132807
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycemic control and treatment patterns in patients with heart failure.
    Tang WH
    Heart Fail Monit; 2006; 5(1):10-4. PubMed ID: 16547530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences with serum BNP (B type natriuretic peptide) in patients with systolic and diastolic heart failure].
    Lukács I; Fey E; Kárpáti P
    Orv Hetil; 2005 Sep; 146(37):1919-23. PubMed ID: 16255376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and heart failure: the role of thiazolidinediones in managing these partners in crime.
    Leier CV; Haas GJ
    J Am Coll Cardiol; 2007 Jul; 50(1):37-9. PubMed ID: 17601543
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical inquiries. Do TZDs increase the risk of heart failure for patients with diabetes?
    Baskin S; Neher JO; Dodson S; Hoffman R
    J Fam Pract; 2005 Aug; 54(8):723-4. PubMed ID: 16061064
    [No Abstract]   [Full Text] [Related]  

  • 12. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heart failure while taking glitazones--what do we know today?].
    Halbritter R
    Dtsch Med Wochenschr; 2009 Jul; 134(28-29):1488; author reply 1488. PubMed ID: 19572255
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.
    Strunk A; Bhalla V; Clopton P; Nowak RM; McCord J; Hollander JE; Duc P; Storrow AB; Abraham WT; Wu AH; Steg G; Perez A; Kazanegra R; Herrmann HC; Aumont MC; McCullough PA; Maisel A
    Am J Med; 2006 Jan; 119(1):69.e1-11. PubMed ID: 16431187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes.
    Sambanis C; Tziomalos K; Kountana E; Kakavas N; Zografou I; Balaska A; Koulas G; Karagiannis A; Zamboulis C
    Acta Diabetol; 2008 Mar; 45(1):23-30. PubMed ID: 17768592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma brain natriuretic peptide levels in the diagnostic and prognostic assessment of patients with heart failure. Pros].
    Metra M; Nodari S; Pedrinazzi C; Rocca P; Manerba A; Vizzardi E; Danesi R; Dei Cas L
    Ital Heart J; 2003 Dec; 4 Suppl 8():59S-67S. PubMed ID: 15005534
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac resynchronization therapy and B-type natriuretic peptide in heart failure.
    Huang DJ
    Chin Med J (Engl); 2009 Mar; 122(6):608-9. PubMed ID: 19323919
    [No Abstract]   [Full Text] [Related]  

  • 19. Releasing the pressure.
    Davenport RJ
    Sci Aging Knowledge Environ; 2005 Jun; 2005(25):nf47. PubMed ID: 15975897
    [No Abstract]   [Full Text] [Related]  

  • 20. N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery.
    Walsh R; Boyer C; LaCorte J; Parnell V; Sison C; Chowdhury D; Ojamaa K
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):98-105. PubMed ID: 18179925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.